Budesonide Foam
Phase 3Terminated 0 views this week 0 watching💤 Quiet
Interest: 26/100
26
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Proctitis
Conditions
Proctitis, Proctosigmoiditis
Trial Timeline
May 31, 2011 → Dec 31, 2014
NCT ID
NCT01349673About Budesonide Foam
Budesonide Foam is a phase 3 stage product being developed by Bausch Health for Proctitis. The current trial status is terminated. This product is registered under clinical trial identifier NCT01349673. Target conditions include Proctitis, Proctosigmoiditis.
What happened to similar drugs?
0 of 3 similar drugs in Proctitis were approved
Approved (0) Terminated (1) Active (2)
Hype Score Breakdown
Clinical
17
Activity
0
Company
9
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01349673 | Phase 3 | Terminated |
Competing Products
3 competing products in Proctitis
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Mesalamine + Canasa + Placebo | Sandoz Group | Phase 3 | 29 |
| Budesonide + Placebo | Bausch Health | Phase 3 | 34 |
| Budesonide + Placebo | Bausch Health | Phase 3 | 34 |